Choose another ingredient

THE INGREDIENT LIBRARY · Entry 598

European mistletoe: Iscador M special

European mistletoe: Iscador M special
Decorative sealed clinician-formulation vial with mistletoe source-plant context; not a depiction of an actual Iscador package, preparation guide or identification reference. Decorative illustration; not an identification reference.

At a glance

A small breast-cancer study of Iscador M special reported quality-of-life improvement; benefit remains uncertain and survival benefit is unproven.

Key cautions

  • Do not eat raw mistletoe or make injections. Severe allergy is possible; any use needs specialist oversight.
  • Mistletoe extracts are not FDA-approved cancer treatments.
Read the full cautions

What’s inside

Mistletoe extracts can contain lectins and viscotoxins; composition varies by host tree, harvest and manufacture. The cited trial defines Iscador M special, not a universal extract.

Uses in brief

  • A small breast-cancer study of Iscador M special reported quality-of-life improvement; benefit remains uncertain and survival benefit is unproven.

History, folklore and reported uses

History, folklore and traditional uses

NCI dates modern cancer interest in mistletoe to the 1920s. Older medicinal traditions do not establish this injection as an effective cancer treatment.

Traditional, historical and reported uses

  1. Twentieth-century cancer-use history
    Historical recordWhy this label?

    Documents this named use; does not support broader disease claims or interchangeable formulations.

    NCI dates modern cancer interest in mistletoe to the 1920s. Older medicinal traditions do not establish this injection as an effective cancer treatment.

Only documented uses are included. Historical practice does not establish clinical benefit or safe home use.

Story sources

Health topics: evidence and cautions

These notes describe a specific research context and preparation. A topic link is not a treatment recommendation.

Cancer by type · Support during care

Form and route: Iscador M special: manufactured fermented aqueous fresh-herb extract from apple-host mistletoe · subcutaneous injection by clinical protocol

A small breast-cancer study reported better quality of life with a specific mistletoe extract.

Evidence: Small clinical study; uncertain benefit

A 95-person, three-arm trial published a comparison of 30 Iscador M special recipients and 31 controls during post-operative breast-cancer chemotherapy; quality-of-life scores favored the extract.

Limits

Open-label, small exploratory comparison of subjective scores: expectations and added injection attention could contribute. No established survival benefit or transfer to other products.

Cautions

  • Do not eat raw mistletoe or make injections. Severe allergy is possible; any use needs specialist oversight.
  • Mistletoe extracts are not FDA-approved cancer treatments.

Read the full Cancer by type topic record

Identity & detailed reference

Identity

Viscum album fresh herb grown on apple host trees, manufactured as Iscador M special. This is not a raw-berry or home-plant remedy.

Ingredient details, preparation and research

Source plant or material

Viscum album fresh herb grown on apple host trees, manufactured as Iscador M special. This is not a raw-berry or home-plant remedy.

Plant family / material: Santalaceae (European mistletoe source)

Forms and route

Defined fermented aqueous fresh-herb extract for clinician-administered subcutaneous use under a clinical protocol. Other mistletoe products are separate.

Vitamins and minerals

This is a clinical research preparation, not a food or nutrient supplement.

Absorption and preparation

Subcutaneous injection is a distinct clinical route. Oral tea, berries and supplements cannot reproduce this exposure.

Traditional and reported uses

  • A small breast-cancer study of Iscador M special reported quality-of-life improvement; benefit remains uncertain and survival benefit is unproven.

Contraindications and cautions

  • Do not eat raw mistletoe or make injections. Severe allergy is possible; any use needs specialist oversight.
  • Mistletoe extracts are not FDA-approved cancer treatments.
  • Only a qualified clinical team should decide whether a studied injection is appropriate. Never prepare or inject a plant extract yourself.

Exact clinical preparation

The primary trial used fermented aqueous fresh apple-host mistletoe extract called Iscador M special. Its published comparison included 30 recipients and 31 controls with early-stage nonmetastatic breast cancer during post-operative CAF chemotherapy (cyclophosphamide, doxorubicin and fluorouracil), within a 95-person three-arm study.

Outcome and bias

Quality-of-life scores favored the extract, but the comparison was small and open label. Subjective scores can be influenced by expectations and extra treatment attention; no survival conclusion follows.

Safety and regulatory boundary

NCI reports injection-site reactions, fever and occasional serious allergy. Mistletoe extracts are not FDA-approved cancer treatments. Raw plant material can be poisonous.

Evidence limits

  • Open-label, small exploratory comparison of subjective scores: expectations and added injection attention could contribute. No established survival benefit or transfer to other products.

Entry sources